Cargando…

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer

BACKGROUND: Natural killer (NK) cells are effective at killing tumors in a non-MHC restricted manner and are emerging targets for cancer therapy but their importance in bladder cancer (BC) is poorly defined. NK cells are commonly subdivided into populations based on relative surface expression of CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Neelam, Ji, Niannian, Hurez, Vincent, Curiel, Tyler J., Montgomery, Maureen O., Braun, Andrew J., Nicolas, Marlo, Aguilera, Marcela, Kaushik, Dharam, Liu, Qianqian, Ruan, Jianhua, Kendrick, Kerri A., Svatek, Robert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284861/ https://www.ncbi.nlm.nih.gov/pubmed/30559932 http://dx.doi.org/10.18632/oncotarget.26362

Ejemplares similares

KLRF1, a novel marker of CD56(bright) NK cells, predicts improved survival for patients with locally advanced bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2022)

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation
por: Reyes, Ryan M, et al.
Publicado: (2021)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations
por: Melsen, Janine E., et al.
Publicado: (2016)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
por: Laroni, Alice, et al.
Publicado: (2020)

Cytotoxicity of Human Hepatic Intrasinusoidal CD56(bright) Natural Killer Cells against Hepatocellular Carcinoma Cells
por: Hwang, Shin, et al.
Publicado: (2019)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Natural killer cells 56(bright)16(−) have higher counts in the umbilical cord blood than in the adult peripheral blood
por: de Molla, Vinicius Campos, et al.
Publicado: (2023)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial
por: Kaushik, Dharam, et al.
Publicado: (2021)

Bladder tumor ILC1s undergo Th17‐like differentiation in human bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2021)

Human Placental Cytotrophoblasts Attract Monocytes and Cd56(bright) Natural Killer Cells via the Actions of Monocyte Inflammatory Protein 1α
por: Drake, Penelope M., et al.
Publicado: (2001)

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study
por: Ji, Niannian, et al.
Publicado: (2021)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

Invasive Surgery Impairs the Regulatory Function of Human CD56(bright) Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis
por: Reinhardt, Renate, et al.
Publicado: (2015)

Circulating growth/differentiation factor 15 is associated with human CD56(bright) natural killer cell dysfunction and nosocomial infection in severe systemic inflammation
por: Kleinertz, Holger, et al.
Publicado: (2019)

The involvement of circulating CD69(+) CD56(bright) natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
por: Chikuie, Emi, et al.
Publicado: (2023)

Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56(bright) Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
por: Ziblat, Andrea, et al.
Publicado: (2018)

The Transcription Factor Promyelocytic Leukemia Zinc Finger Protein Is Associated With Expression of Liver‐Homing Receptors on Human Blood CD56(bright) Natural Killer Cells
por: Hess, Leonard U., et al.
Publicado: (2020)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

Natural Killer Cell Cytokine Response to M. bovis BCG Is Associated with Inhibited Proliferation, Increased Apoptosis and Ultimate Depletion of NKp44(+)CD56(bright) Cells
por: Portevin, Damien, et al.
Publicado: (2013)

The Increased Ratio of Blood CD56(bright) NK to CD56(dim) NK Is a Distinguishing Feature of Primary Sjögren's Syndrome
por: Ming, Bingxia, et al.
Publicado: (2020)

Ageing is associated with a decline in peripheral blood CD56(bright )NK cells
por: Chidrawar, Shivani M, et al.
Publicado: (2006)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
por: Yamaki, Toshiaki, et al.
Publicado: (1988)

Impaired intratumoral natural killer cell function in head and neck carcinoma
por: Mele, Dalila, et al.
Publicado: (2022)

Diffusion of robot-assisted radical cystectomy: Nationwide trends, predictors, and association with continent urinary diversion
por: Elshabrawy, Ahmed, et al.
Publicado: (2022)

The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56(bright) NK cells
por: Ziegler, Annerose E., et al.
Publicado: (2023)

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56(dim)CD16(+) and CD56(bright)CD16(dim/−) natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Huth, Teilah Kathryn, et al.
Publicado: (2016)

Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells
por: Yu, Qin, et al.
Publicado: (2022)

Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells
por: Haque Chowdhury, Helena, et al.
Publicado: (2021)

Single-cell profiling reveals periventricular CD56(bright) NK cell accumulation in multiple sclerosis
por: Rodríguez-Lorenzo, Sabela, et al.
Publicado: (2022)

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation
por: Reyes, Ryan Michael, et al.
Publicado: (2021)

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells
por: Ziegler, Sabrina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ffq7qlc80heeq5qlsg17an6km